AFP - C-terminal region Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-AFP - C-terminal region antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAFP - C-terminal region
Clonepolyclonal
Host SpeciesRabbit
Reactive Speciescow, dog, horse, human, mouse, porcine, rat
Isotypen/a
Formatunconjugated
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis is a rabbit polyclonal antibody against AFP. It was validated on Western BlotTarget Description: This gene encodes alpha-fetoprotein, a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistance of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin.
ImmunogenImmunogen: The immunogen is a synthetic peptide directed towards the C-terminal region of Human AFP
Other Names[alpha-fetoprotein isoform 1; Alpha-fetoprotein; alpha-fetoprotein; alpha fetoprotein; Alpha-1-fetoprotein; Alpha-fetoglobulin]
Gene, Accession #[AFP], Gene ID: 174, NCBI: NP_001125, UniProt: P02771
Catalog #MBS3200223
Price$270
Order / More InfoAFP - C-terminal region Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.